Skip to content

International Conference on Drug Discovery and Translational Medicine 2025 (ICDDTM'25)

Fostering Global Interdisciplinary Collaboration for Sustainable Innovation in Drug Discovery and Translational Medicine

Venue: Hospital Sultan Abdul Aziz Shah (HSAAS), Universiti Putra Malaysia (UPM), Serdang, Selangor
Date: 24-25 November (Pre-Conference Workshops) & 26-27 November 2025 (ICDDTM'25 Conference)
Menu
  • Home
    • Welcome and Selamat Datang
    • Committee Members
    • Gallery
    • The Venue
      • Nearby Hotels
  • Programme Schedule
    • Programme Schedule
    • Why You Should Attend
    • Plenary & Invited Speakers
    • Pre-Conference Workshops
      • Pharmacometrics
      • Conducting Clinical Trials
      • AI and Machine Learning in Drug Discovery: From Target Identification to Personalised Medicine
      • Network Pharmacology
      • All Topics
    • Special Forums
    • ICDDTM’25 Posters
  • Register
  • Submit Abstract
    • Author’s Guideline
      For Abstract
      • General Guidelines For Oral Presentation
      • General Guidelines For Poster Presentation
    • Awards
      • Travel Awards
  • Contact
  • F.A.Q.
  • Be A Sponsor
Menu

Professor Dr K. Miraz Rahman

Professor Dr K. Miraz Rahman
Drug Design & Synthesis
King’s College London, United Kingdom

———————————————————————-

Professor Dr K. Miraz Rahman is a Professor of Medicinal Chemistry at King’s College London, with extensive expertise in both early- and late-stage drug discovery. He graduated as a pharmacist from the Faculty of Pharmacy at the University of Dhaka, Bangladesh, in 1996. After three years in the industry, he transitioned to academia, completed his PhD in synthetic medicinal chemistry at the London School of Pharmacy (now UCL School of Pharmacy), and worked as a CRUK Research Fellow for three years. In 2012, he joined King’s College London as a Lecturer and was subsequently promoted to Chair in Medicinal Chemistry in 2021.

He currently serves as Head of the Drug Discovery Research Division at King’s College London. Additionally, he is the Antimicrobial Research Theme Lead and Director of the MRC DTP iCASE Programme, one of the largest UKRI-funded industrial PhD programmes in the UK.  His research focuses on the application of advanced computational chemistry, synthetic medicinal chemistry, and chemical biology techniques to design, synthesize, and evaluate novel drug-like chemical scaffolds as anticancer and antimicrobial agents.

Miraz is committed to translating innovative laboratory research into commercialization and patient care. He holds 20 patents as an inventor and has co-founded several university spin-out companies, including Pheon Therapeutics, a clinical-stage company developing first-in-class antibody-drug conjugates for the treatment of solid tumours.

Note: Click [x] on top-right or anywhere outside this pop-up to exit

 

Category:

Venue:
Hospital Sultan Abdul Aziz Shah (HSAAS), Universiti Putra Malaysia (UPM), Serdang, Selangor

ICDDTM'25 Flyer

Right click and Save As ICDDTM'25 Poster

All abstracts will be published in an indexed (Scopus or WoS) journal

Disclaimer

The information on this website is regularly updated to reflect the latest developments. While we strive for accuracy, details may change without prior notice.

All claims on the advertisements stated in this website are those of the vendors and journals and do not reflect the official position or endorsement from the organisers of ICDDTM'25. The organisers of ICDDTM'25 acknowledge the importance of having research data to substantiate all advertisement claims, and the research or citation is to be made available on the vendors’ and journals’ website or, where proprietary interests exist, be made available upon request.

Flag Counter
(Dr. D Y. Patil Dnyan Prasad University, Pune, India)
(Nirma University, India)
(University of Asia Pacific, Bangladesh)
(University of Gajah Mada, Indonesia)
(Birla Institute of Technology Mesra, India)
(The Halifax Institute, Canada)
(Jashore University of Science and Technology, Bangladesh)
(Yantai Affiliated Hospital of Binzhou Medical University, China)
(Universitas Andalas, Padang, Indonesia)
(Dhaka University, Bangladesh)
© 2025 International Conference on Drug Discovery and Translational Medicine 2025 (ICDDTM'25) | Organised by Malaysian Association for Cancer Research